GLP-1RA Therapy - Part 1
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this opening episode of our two-part series, Dr. Mark Bartlett and Dr. Alan Jones introduce the fundamental science behind GLP-1 receptor agonists, moving beyond the headlines to explore how these therapies actually function within the body. We weigh the significant metabolic benefits against potential drawbacks, providing a balanced look at the pros and cons of synthetic therapy. A central focus is the concept of "half-life"—understanding how long these molecules remain active in your system and why that timing is critical for managing both results and the biological "rebound" effect.
We dive into the efficacy of naturally occurring peptides and how supporting your body’s endogenous production can, for many, be a more sustainable and effective route than clinical alternatives.